posted on 2011-12-31, 02:36authored byPhilippe Leissner, Thibault Verjat, Thomas Bachelot, Malick Paye, Alexander Krause, Alain Puisieux, Bruno Mougin
Copyright information:
Taken from "Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancer"
BMC Cancer 2006;6():216-216.
Published online 31 Aug 2006
PMCID:PMC1564186.
The high expression group (n = 44; 15 events) did not show significantly poorer BCS rates than the low expression group (n = 43; 8 events; p = 0.19, log-rank test).